Navigation Links
Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting
Date:3/6/2009

on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    Contact:
    Kayla Castle
    Investor Relations Manager
    Palomar Medical Technologies Inc
    781-993-2411
    ir@palomarmedical.com


'/>"/>
SOURCE Palomar Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008
2. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
3. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
4. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
5. Palomar Medical Reports Financial Results for Third Quarter 2008
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
8. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
9. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
10. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
11. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... ... official ready-to-drink sponsor of two leading organizations dedicated to raising worldwide awareness of ... , I AM ADAPTIVE™ is now the official charity of FitAID. I AM ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood ... contest today. Why We Care Youth serves as a platform for young people living ... meant to them, and why U.S. policymakers should care about expanding access around the ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... device market research, has launched a new reimbursement insurance policy tracking and analysis ... to receive US insurance policy and rate updates in real-time from hundreds of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Tulika Ranjan, MD, a prominent ... (AHN) as Director of its Adult Neuro-Oncology program. , Dr. ... metastases, leptomeningeal disease and the neurological complications of cancer. She has special ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... national testosterone claims alleging heart attack and stroke incidents are linked to testosterone ... Day. The Case Management Conference is scheduled for July 9, 2015, according to ...
Breaking Medicine News(10 mins):Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:iData Research Introduces New Medical Insurance Reimbursement Policy & Rate Tracker Subscription Service 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4
... who suffer a heart attack or severe chest pain today are ... their counterparts// even a few years ago, according to a new ... has shown a significant drop in the rate of heart failure ... ,The study finds that the change occurred at the ...
... are used to shock the heart back to normal are found ... of five fails to work after just ten years. On research ... , The wire or the lead sometimes shocked the ... abnormally or completely stopped. ,Many a times it causes ...
... to a Group of Ministers (GOM) though no timeframe has ... ,The policy envisages ways to make available cheaper ... to promote the production and marketing of generic drugs in ... and fertilisers and parliamentary affairs. ,The policy ...
... of marijuana on humans has come to light. //It ... hallucinations and paranoid delusions, it has been found. ... or CBD, made people more relaxed. But even small ... psychotic symptoms in people, including hallucinations and paranoid delusions, ...
... WA) has agreed to pay the US $10.5 millon ... of the anti-cancer prescription drug Trisenox, the US Justice ... the government's complaint, CTI promoted the drug for various ... Drug Administration (FDA). ,The alleged "off-label" uses ...
... After hurricane Katrina what can be worse? Apparently, the region ... healthcare// , mainly due to the shortage of practicing doctors. ... to pick up the threads of their life, post Katrina. ... met a watery end. Most hospitals are seen managing huge ...
Cached Medicine News:Health News:Good News for Sufferers of Heart Attack, Chest Pain 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 3Health News:Good News for Sufferers of Heart Attack, Chest Pain 4Health News:Marijuana can Trigger Psychotic Symptoms, New Study Finds 2Health News:CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG 2
(Date:6/30/2015)...  EnteroMedics Inc. (NASDAQ: ETRM ), a developer ... treat obesity, metabolic diseases, and other gastrointestinal disorders, announced ... 40,229,886 units. Each unit consists of one share of ... purchase one share of common stock, and 0.50 of ... common stock, at a purchase price of $0.87 per ...
(Date:6/30/2015)... Calif. and COPENHAGEN, Denmark ... Inc. , a global leader in clinical and commercial ... today that, as part of its global manufacturing capacity ... North American manufacturing facility in Bothell, Washington ... 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists of six ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... Cepheid (Nasdaq: CPHD ) today announced that ... Vice President of Infectious Disease Research and Development, reporting ... offers an impressive menu of eleven highly regarded Xpert® ... aggressively to extend our leadership with next-generation products, including ...
... 2011 In a recent announcement by Neurelis, ... positive clinical results in a Phase I pharmacokinetic ... at Particle Sciences.  In the Phase 1 clinical ... that reported in the literature for Diastat® (rectal ...
Cached Medicine Technology:Cepheid Appoints Vice President of Infectious Disease Research & Development 2Cepheid Appoints Vice President of Infectious Disease Research & Development 3Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) 2
... The table-mounted hip ... hands-free exposure for total ... to accommodate individual surgeon ... of any size. Hand-held ...
... gelatinase-associated lipocalin, lipocalin-2) is a new early ... renal failure with a >90% positive predictive ... urine, as early as 2 hours after ... diagnostic marker for acute renal failure. ,Quantitative ...
... "Beautiful tissue is how one neurosurgeon describes ... Needle. By "beautiful he means a,cleaner cut ... are,functions of the needles optimized vacuum and ... captive locking thumb nut holds vacuum,in the ...
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
Medicine Products: